Solius Labs Launches Innovative Light Therapy Device
Bainbridge Island, Wash. — Solius Labs has made an exciting announcement, unveiling its new product, Solius Pro. This is the world’s first FDA-cleared personalized UVB light therapy device that can be used without a prescription.
Solius Labs utilizes a unique skin analysis system that determines the ideal UVB light dose for each user based on their individual skin tone. Users can enjoy the healthy benefits of sunlight through just five minutes of weekly use.
The FDA has recognized Solius Pro as a novel health technology by issuing a new product code, placing it in a category all its own. This innovation makes it easier for individuals to safely receive the advantages of UVB light therapy, promoting overall health without needing specialized medical prescriptions.
This launch is a significant step forward in personalized health solutions, showcasing how technology can enhance our well-being in everyday life.
